These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34169667)

  • 41. Prominent hypointense veins on susceptibility weighted image in the cat brain with acute infarction: DWI, SWI, and PWI.
    Kim YW; Kim HJ; Choi SH; Kim DC
    Acta Radiol; 2014 Oct; 55(8):1008-14. PubMed ID: 24136983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas.
    Yang Y; Yang Y; Wu X; Pan Y; Zhou D; Zhang H; Chen Y; Zhao J; Mo Z; Huang B
    J Neurooncol; 2020 Jan; 146(2):363-371. PubMed ID: 31902040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients.
    Kerkhof M; Tans PL; Hagenbeek RE; Lycklama À Nijeholt GJ; Holla FK; Postma TJ; Straathof CS; Dirven L; Taphoorn MJ; Vos MJ
    CNS Oncol; 2017 Oct; 6(4):297-306. PubMed ID: 28984142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of intravoxel incoherent motion magnetic resonance imaging and arterial spin labeling for recurrent glioma after bevacizumab treatment.
    Miyoshi F; Shinohara Y; Kambe A; Kuya K; Murakami A; Kurosaki M; Ogawa T
    Acta Radiol; 2018 Nov; 59(11):1372-1379. PubMed ID: 29471670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
    Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
    Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between CT and MR in perfusion imaging assessment of high-grade gliomas.
    De Simone M; Muccio CF; Pagnotta SM; Esposito G; Cianfoni A
    Radiol Med; 2013 Feb; 118(1):140-51. PubMed ID: 22430675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Perfusion magnetic resonance imaging for high grade astrocytomas: Can cerebral blood volume, peak height, and percentage of signal intensity recovery distinguish between progression and pseudoprogression?].
    Martínez-Martínez A; Martínez-Bosch J
    Radiologia; 2014; 56(1):35-43. PubMed ID: 23790618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
    Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S
    J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
    Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
    Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.
    McDonald CR; Delfanti RL; Krishnan AP; Leyden KM; Hattangadi-Gluth JA; Seibert TM; Karunamuni R; Elbe P; Kuperman JM; Bartsch H; Piccioni DE; White NS; Dale AM; Farid N
    Neuro Oncol; 2016 Nov; 18(11):1579-1590. PubMed ID: 27106406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
    Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
    Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.
    Cuccarini V; Erbetta A; Farinotti M; Cuppini L; Ghielmetti F; Pollo B; Di Meco F; Grisoli M; Filippini G; Finocchiaro G; Bruzzone MG; Eoli M
    J Neurooncol; 2016 Jan; 126(2):279-88. PubMed ID: 26468137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC; Watkins TW; Kwan GN; Haacke EM
    J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contrast enhancing spots as a new pattern of late onset pseudoprogression in glioma patients.
    Voss M; Franz K; Steinbach JP; Fokas E; Forster MT; Filipski K; Hattingen E; Wagner M; Breuer S
    J Neurooncol; 2019 Mar; 142(1):161-169. PubMed ID: 30604393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.
    Abbasi AW; Westerlaan HE; Holtman GA; Aden KM; van Laar PJ; van der Hoorn A
    Clin Neuroradiol; 2018 Sep; 28(3):401-411. PubMed ID: 28466127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pseudoprogression in pediatric low-grade glioma after irradiation.
    Tsang DS; Murphy ES; Lucas JT; Lagiou P; Acharya S; Merchant TE
    J Neurooncol; 2017 Nov; 135(2):371-379. PubMed ID: 28752498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas.
    Lee WJ; Choi SH; Park CK; Yi KS; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH
    Acad Radiol; 2012 Nov; 19(11):1353-61. PubMed ID: 22884399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas.
    Zikou A; Sioka C; Alexiou GA; Fotopoulos A; Voulgaris S; Argyropoulou MI
    Contrast Media Mol Imaging; 2018; 2018():6828396. PubMed ID: 30627060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images.
    Sengupta A; Agarwal S; Gupta PK; Ahlawat S; Patir R; Gupta RK; Singh A
    Eur J Radiol; 2018 Sep; 106():199-208. PubMed ID: 30150045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.